Equivalence codes
Equivalence codes
This system allows users to quickly determine if the Food and Drug Administration has evaluated a particular drug and determined it to be therapeutically equivalent to another drug.
A: drug products FDA considers therapeutically equivalent to other pharmaceutically equivalent products;
AA: drug products for which there are no known or suspected bioequivalence problems (also AN, AO, AP, AT, depending on dosage form);
AB: drug products for which actual or potential bioequivalence problems have been resolved with adequate in vivo and/or in vitro evidence supporting bioequivalence;
B: drug products that FDA considers not to be therapeutically equivalent to other pharmaceutically equivalent products; in other words, actual or potential bioequivalence problems have not been resolved by adequate evidence of bioequivalence.
Source: Approved Drug Products. 16th ed. Rockville, MD: U.S. Department of Health and Human Services; 1996.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.